Parvovirus B19 In HIV infection: A treatable cause of anemia
References (20)
- et al.
Parvovirus-like particles in human sera
Lancet
(1975) - et al.
Manifestations and treatment of human parvovirus B 19 infection in immunocompromised patients
J Paediat
(1990) - et al.
Pathophysiology and management of HIV-associated hematologic disorders
Blood
(1989) - et al.
Letter: Parvovirus B 19 related pancytopenia in children with HIV infection
Lancet
(1992) - et al.
Rapid detection of human parvovirus infection by dot-blot hybridisation and the polymerase chain reaction
J Virol Methods
(1989) Hematologic and hematopoietic consequences of B19 parvovirus infection
Semin Hematol
(1988)- et al.
Pure red cell aplasia of 10 years duration due to persistent parvovirus B 19 infection and its cure with immunoglobulin therapy
N Eng J Med
(1989) - et al.
Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus — 1: a treatable cause of anemia in AIDS
Ann Intern Med
(1990) - et al.
Parvovirus B19 Infection in Human Immunodeficiency Virus Type 1-infected persons failing or intolerant to zidovudine
J of Infectious Diseases
(1993) - et al.
Letter: Red cell aplasia associated with human parvovirus B19 and HIV infection: failure to respond clinically to intravenous immunoglobulin
AIDS
(1990)
Cited by (24)
Parvovirus B19: a Clinical and Diagnostic Review
2022, Clinical Microbiology NewsletterCitation Excerpt :Clinical manifestations of B19V infections in these patients include fatigue and pallor, often in the absence of rash and arthralgia [46]. Anemia often promptly remits after immunoglobulin therapy or cessation of chemotherapy [54,55]. People with decreased red cell production, increased destruction, or loss are at risk of developing transient aplastic crisis following B19V infection (Table 1).
Reactivation of parvovirus B19 infection in an HIV-infected woman
2014, Revue de Medecine InterneViruses and Kidney Disease: Beyond HIV
2008, Seminars in NephrologyCitation Excerpt :Among immunocompromised individuals, including those receiving immunosuppressive therapy and those infected with HIV, B19 infection can become persistent as a result of the inability to mount an effective humoral and/or cellular response. Pure red cell aplasia is the most common presentation of persistent parvoviral infection in HIV-infected patients.87-90 Whether parvovirus infection has any pathogenic role in renal or urologic disease in HIV-infected patients is unknown.
Detection of human parvovirus B19 infection: A study of 212 suspected cases in the state of Rio de Janeiro, Brazil
2002, Journal of Clinical VirologyAnemia normocítica normocrómica con reagudizaciones frecuentes en un paciente con sida
2002, Enfermedades Infecciosas y Microbiologia Clinica